BML Capital Management

BML Capital Management as of March 31, 2024

Portfolio Holdings for BML Capital Management

BML Capital Management holds 30 positions in its portfolio as reported in the March 2024 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Ishares Tr 0-3 Mnth Treasry (SGOV) 18.2 $27M 270k 100.71
Atea Pharmaceuticals (AVIR) 15.0 $22M 5.5M 4.04
Spdr Ser Tr Bloomberg 1-3 Mo (BIL) 12.3 $18M 200k 91.80
Adverum Biotechnologies Com New 7.9 $12M 833k 14.14
Aclaris Therapeutics (ACRS) 7.8 $12M 9.4M 1.24
Cyteir Therapeutics 7.4 $11M 3.7M 3.01
Eliem Therapeutics (ELYM) 4.0 $6.0M 2.2M 2.74
Avrobio Ord (AVRO) 3.4 $5.1M 4.0M 1.28
Instil Bio Com New (TIL) 2.5 $3.8M 349k 10.80
Reneo Pharmaceuticals (RPHM) 2.4 $3.6M 2.2M 1.66
Connect Biopharma Hldgs Ads (CNTB) 2.4 $3.6M 2.1M 1.74
Design Therapeutics (DSGN) 2.4 $3.5M 880k 4.03
Athira Pharma (ATHA) 1.7 $2.5M 900k 2.74
Oramed Pharmaceuticals Com New (ORMP) 1.7 $2.5M 845k 2.92
Pmv Pharmaceuticals (PMVP) 1.5 $2.2M 1.3M 1.70
Astrotech Corp (ASTC) 1.3 $2.0M 220k 8.95
Lenz Therapeutics 1.0 $1.4M 64k 22.33
Kinnate Biopharma (KNTE) 0.9 $1.3M 499k 2.66
Arca Biopharma (ABIO) 0.8 $1.2M 707k 1.76
Forte Biosciences (FBRX) 0.8 $1.2M 1.8M 0.70
Milestone Pharmaceuticals (MIST) 0.7 $1.1M 606k 1.79
Verrica Pharmaceuticals (VRCA) 0.7 $1.1M 180k 5.92
Lisata Therapeutics (LSTA) 0.6 $888k 285k 3.12
Enliven Therapeutics (ELVN) 0.6 $881k 50k 17.59
Vistagen Therapeutics Ord (VTGN) 0.5 $792k 150k 5.28
Nextcure (NXTC) 0.5 $683k 307k 2.23
Calcimedica Com New (CALC) 0.4 $667k 160k 4.16
Q32 Bio 0.3 $424k 25k 17.04
Talis Biomedical Corp Com New (TLIS) 0.3 $374k 43k 8.75
Allovir (ALVR) 0.1 $151k 201k 0.75